Information  X 
Enter a valid email address

JPMorgan Glbl Con In (JGCI)

  Print   

Thursday 11 July, 2019

JPMorgan Glbl Con In

Company Update

RNS Number : 2936F
JPMorgan Glbl Con Inc Fnd Ltd
11 July 2019
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN GLOBAL CONVERTIBLES INCOME FUND LIMITED

 

 

COMPANY UPDATE

 

 

Legal Entity Identifier: 549300DKZ0OX0PZH5H23

 

The information contained within this announcement constitutes inside information.

 

At the AGM to be convened in November the Board of JPMorgan Global Convertibles Income Fund Limited (the 'Company') was due to put to the Company's shareholders a resolution to approve the continuation of the Company. The Board has been pleased with the Company's performance since the appointment of Hart Woodson as Head of JPMorgan Asset Management's Convertible Bond team; however, having received feedback from a significant proportion of the Company's shareholders the Board is not confident that there will be sufficient support for continuation.

 

Accordingly, the Board does not intend to put forward the continuation vote and is considering putting alternative proposals to the Company's shareholders for the orderly liquidation of the Company, returning cash to shareholders at NAV less costs (the 'Proposals').  The Proposals may also include the option for shareholders to rollover some or all of their investment. The Company will make further announcements in due course.

 

The person responsible for arranging for the release of this announcement on behalf of the Company is Jonathan Latter of JPMorgan Funds Limited.

 

ENQUIRIES

 

 

For and on behalf of

JPMorgan Funds Limited

11th July 2019

 

For further information, please contact:

 

JPMorgan Funds Limited 

Katie Standley/Jonathan Latter

020 7742 4000

 

Winterflood Securities Limited Joe Winkley/Neil Morgan

020 3100 0000

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
UPDEFLFFKDFZBBK

a d v e r t i s e m e n t